Literature DB >> 7512516

Fetal valproate syndrome: clinical and neuro-developmental features in two sibling pairs.

A L Christianson1, N Chesler, J G Kromberg.   

Abstract

The clinical and neurodevelopmental features are presented of four children--two sibling pairs--who were exposed in utero to valproic acid. One of each pair of children presented for diagnosis and assessment of developmental delay; the other sibling was examined at a later date. Three of the children were globally developmentally delayed with marked speech disability, and had dysmorphic features consistent with fetal valproate syndrome. One also had features of infantile autism. The fourth child had some of the dysmorphic features connected with fetal valproate syndrome, but had normal intellect, with his verbal ability being significantly below his non-verbal ability. He currently attends a school for learning-disabled children.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7512516     DOI: 10.1111/j.1469-8749.1994.tb11858.x

Source DB:  PubMed          Journal:  Dev Med Child Neurol        ISSN: 0012-1622            Impact factor:   5.449


  73 in total

1.  Fatal cardiac malformation in fetal valproate syndrome.

Authors:  P Sodhi; B Poddar; V Parmar
Journal:  Indian J Pediatr       Date:  2001-10       Impact factor: 1.967

2.  Elevated NMDA receptor levels and enhanced postsynaptic long-term potentiation induced by prenatal exposure to valproic acid.

Authors:  Tania Rinaldi; Karina Kulangara; Katia Antoniello; Henry Markram
Journal:  Proc Natl Acad Sci U S A       Date:  2007-08-03       Impact factor: 11.205

3.  Associations between indoor environmental factors and parental-reported autistic spectrum disorders in children 6-8 years of age.

Authors:  Malin Larsson; Bernard Weiss; Staffan Janson; Jan Sundell; Carl-Gustav Bornehag
Journal:  Neurotoxicology       Date:  2009-02-10       Impact factor: 4.294

4.  Mouse models of autism: testing hypotheses about molecular mechanisms.

Authors:  Florence I Roullet; Jacqueline N Crawley
Journal:  Curr Top Behav Neurosci       Date:  2011

Review 5.  Treatment of Juvenile Myoclonic Epilepsy in Patients of Child-Bearing Potential.

Authors:  Anna Serafini; Elizabeth Gerard; Pierre Genton; Arielle Crespel; Philippe Gelisse
Journal:  CNS Drugs       Date:  2019-03       Impact factor: 5.749

6.  Association of autism with polyomavirus infection in postmortem brains.

Authors:  Carla Lintas; Laura Altieri; Federica Lombardi; Roberto Sacco; Antonio M Persico
Journal:  J Neurovirol       Date:  2010-03       Impact factor: 2.643

7.  Degraded auditory processing in a rat model of autism limits the speech representation in non-primary auditory cortex.

Authors:  C T Engineer; T M Centanni; K W Im; M S Borland; N A Moreno; R S Carraway; L G Wilson; M P Kilgard
Journal:  Dev Neurobiol       Date:  2014-04-04       Impact factor: 3.964

Review 8.  Developmental effects of antiepileptic drugs and the need for improved regulations.

Authors:  Kimford J Meador; David W Loring
Journal:  Neurology       Date:  2015-10-30       Impact factor: 9.910

9.  Investigation of maternal genotype effects in autism by genome-wide association.

Authors:  Han Yuan; Joseph D Dougherty
Journal:  Autism Res       Date:  2014-02-25       Impact factor: 5.216

Review 10.  Epigenomic strategies at the interface of genetic and environmental risk factors for autism.

Authors:  Janine M LaSalle
Journal:  J Hum Genet       Date:  2013-05-16       Impact factor: 3.172

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.